Investigating how VHL tumor suppressor affects kidney cancer
New Von Hippel Lindau (VHL) tumor suppressor signaling in renal cancer
This study is looking at a type of kidney cancer called clear cell renal cell carcinoma and how a specific gene, VHL, affects cancer cells, with the hope of finding new ways to treat patients who have this challenging condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10997272 on NIH RePORTER |
What this research studies
This research focuses on clear cell renal cell carcinoma (ccRCC), a type of kidney cancer that is often resistant to treatment. It explores the role of the von Hippel-Lindau (VHL) tumor suppressor and its interaction with a specific RNA modification process called m6A, which may influence cancer cell behavior. By analyzing gene expression in kidney cells with and without VHL, the research aims to uncover new therapeutic targets that could improve treatment outcomes for patients with VHL-deficient ccRCC.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with clear cell renal cell carcinoma, particularly those with VHL deficiency.
Not a fit: Patients with other types of kidney cancer or those whose cancer is not associated with VHL may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for patients with advanced kidney cancer that are currently difficult to treat.
How similar studies have performed: Previous research has shown promising results in targeting m6A modifications in cancer, suggesting that this approach may yield valuable insights and potential breakthroughs.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Zhang, Qing — Ut Southwestern Medical Center
- Study coordinator: Zhang, Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.